Biomea Fusion BMEA
NASDAQ BMEA
$0.59 +0.04 (+7.92%)
As of: Nov 11, 2026 · 11:31 AM EST

Biomea Fusion (BMEA) Debt Ratio (2020 - 2022)

Updated

Biomea Fusion's Debt Ratio came in at 0.00 for Q1 2021, up 4.4% from the prior quarter.

Analysis

Biomea Fusion (BMEA) Debt Ratio (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Biomea Fusion 39.97 Mn -121.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00
API Access

Biomea Fusion Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BMEA&period=max&api_key=YOUR_API_KEY